Related Experiment Video
Updated: Aug 12, 2026
10:08
Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
Published on: February 17, 2018
Why we need new strategies in CHF management
1University of Glasgow, Glasgow, G12 8QQ, UK. j.mcmurray@bio.gla.ac.uk
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|April 23, 2002
Summary
Congestive heart failure (CHF) management needs improvement due to rising prevalence. Angiotensin II type 1 receptor blockers show promise, alongside enhanced patient education and monitoring by nurses for better treatment compliance.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Congestive heart failure (CHF) prevalence is increasing, driven by an aging population and improved myocardial infarction survival.
- Current drug therapies require enhancement for effective CHF management.
Purpose of the Study:
- To explore the potential of angiotensin II type 1 (AT(1))-receptor blockers in CHF management.
- To highlight the role of specialized nurses in improving patient compliance and holistic CHF care.
Main Methods:
- Review of early trials and ongoing large-scale outcome studies on AT(1)-receptor blockers for CHF.
- Emphasis on the integration of patient education and monitoring by nurses.
Main Results:
- AT(1)-receptor blockers demonstrate placebo-like tolerability and promising early trial results for CHF.
- Specially trained nurses can improve adherence to existing and novel CHF therapies.
Conclusions:
- AT(1)-receptor blockers represent a potential advancement in CHF treatment strategies.
- Enhanced patient education and monitoring by nurses are crucial for optimizing CHF management and improving patient outcomes.
Related Concept Videos
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:18Chronic Kidney Disease IV: Nursing Management
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...